Skip to main content
AAEM25 Main banner
Back
Evaluation

Scientific Assembly

Track Session

Session: Session 212

Emergency Department Management of Opioid Use Disorder: Best Practices 2025

Tuesday, April 8, 2025
4:40pm – 5:30pm ET
Location: Versailles - 2nd Level
CE: 0.75 CME Credit
Addiction Medicine / Controlled Substance Prescribing Recorded Session

    Panel Moderator(s)

  • Zachary Repanshek, MD

    Professor of Clinical Emergency Medicine
    Lewis Katz School of Medicine, Temple University
    Gladwyne, Pennsylvania

    Disclosure(s): No financial relationships to disclose

    • Panelist(s)

  • Jessica Moore, MD FAAEM FASAM (she/her/hers)

    Assistant Professor of Clinical Emergency Medicine
    Lewis Katz School of Medicine at Temple University
    Philadelphia, Pennsylvania

    Disclosure(s): No financial relationships to disclose

  • Joshua J. Lynch, DO, FAAEM, FACEP

    Associate Professor of Emergency & Addiction Medicine
    University at Buffalo
    Buffalo, New York

    Disclosure(s): No financial relationships to disclose

  • Joshua J. Davis, MD FAAEM

    Assistant Medical Director
    Vituity
    Wichita, Kansas

    Disclosure(s): Doximity: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); IQVIA: Consultant/Advisory Board (Terminated, October 31, 2023)

  • Emma Furlano, MD (she/her/hers)

    Assistant Professor, Emergency Medicine, Division of Medical Toxicology and Addiction Medicine, Albany Medical College
    Albany Medical College
    Albany, New York

    Disclosure(s): No financial relationships to disclose

    • Session Moderator(s)

  • Bruce M. Lo, MD, MBA, FAAEM (he/him/his)

    Professor and Chief
    Eastern Virginia Medical School, Sentara Norfolk General Hospital
    Virginia Beach, Virginia

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Zachary Repanshek, MD: No financial relationships to disclose
Jessica Moore, MD FAAEM FASAM: No financial relationships to disclose
Joshua J. Lynch, DO, FAAEM, FACEP: No financial relationships to disclose
Joshua J. Davis, MD FAAEM: Doximity: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); IQVIA: Consultant/Advisory Board (Terminated, October 31, 2023)
Emma Furlano, MD: No financial relationships to disclose
A panel of experts will share their experiences and give actionable insight on how emergency physicians can manage the challenges associated with opioid use disorder and better serve this vulnerable group in an effective and compassionate manner.

The session will include a moderated discussion on the following:
-Management of opioid withdrawal and initiation of buprenorphine
-Innovations in linking patients to care and optimizing retention in treatment
-Discussing current and upcoming challenges in the management of OUD in the ED

Learning Objectives:

  • Demonstrate the effective treatment of opioid withdrawal in the emergency department including a variety of induction techniques for buprenorphine.
  • Describe linkage strategies for patients in the ED for ongoing management of their opioid use disorder.
  • Summarize the current and anticipated ongoing challenges in the management of OUD in the ED.